Complications in oral implantology associated with maxillary sinus lifting by Atamni, Fahim
RESEARCH STUDIES
Introduction
The rehabilitation of the posterior teeth of the maxilla with 
implant-supported restoration represents a unique clinical 
challenge. Posterior maxillary bone is typically soft due to its 
thin or very spongiotic trabeculae or the absence of cortex, 
which may lead to the implant’s primary stability but ulti-
mately to its failure [6]. To overcome this biomechanical 
disadvantage different therapeutic strategies have been devel-
oped. These include under drilling protocols, modified im-
plant designs, the usage of different bone condensers. Follow-
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Abstract
Objectives: The aim of this study is to evaluate the complications with the elevation of maxillary sinus bottom in dental implantation and identify 
the factors, that may contribute to the occurrence of these complications, and propose different therapeutic approaches. Material and methods: The 
studied population has consisted of 685 patients (971 sinuses) with severe posterior maxillary atrophy treated with sinus bottom elevation by means of 
the lateral window access by one/two stage technique. For unilateral procedures 399 patients have been appointed and for bilateral procedures – 286 
patients. The sinus elevation has been performed with the usage of deproteinized bovine bone material (DBBM) only or its 1:1 mixture with autogenous 
bone as well as β-tricalcium only or its 1:1 mixture with autogenous bone. The complications have been evaluated clinically and radio graphically. Results: 
The most common intraoperative complication has been the sinus membrane perforation which has been observed in 44 sinuses operations (4.5%). 
Severe intraoperative bleeding has been observed in 42 operations on sinuses (4.3%), 22 sinuses (2.3%) of 22 patients have acquired sinus graft infection, 
twelve of the patients have been smokers. The implant migration into maxillary sinus has been reported in two cases (0.2%). Wound dehiscence has been 
observed in 13 cases (1.3%). Periimplant infection has been observed in 23 patients with 54 implants, 8 of them have been removed (0.67%). Conclusion: 
The clinical outcome confirms the fact that sinus bottom elevation to improve the conditions for installing the dental implants can be considered as a 
safe treatment with a low frequency of complications. Proper patients’ selection and treatment planning as well as the application of the sinus elevation 
technique are the prerequisites to minimize the risk of complications.
Key words: dental implantology, sinus bottom elevation, maxillary sinus grafts.
Осложнения при зубной имплантации с поднятием дна верхнечелюстной пазухи
Ф. Атамни
Реферат
Цель. Выявление частоты, причин возникновения и разработка методов лечения осложнений при поднятии дна верхнечелюстной пазухи 
в зубной имплантации. Материал и методы. У 685 пациентов (971 пазуха) с выраженной атрофией заднего отдела верхней челюсти было 
проведено поднятие дна  верхнечелюстной пазухи латеральным доступом, техникой в один или два этапа. В качестве пластического материала 
использована депротеинизированная бычья кость или её смесь (1:1) с костным аутотрансплантатом, а также трикальций фосфат в чистом 
виде или его смесь (1:1) с костным аутотрансплантатом. Oдностороннее поднятие дна пазухи проведено у 399 пациентов, двустороннее – у 286. 
Анализ осложнений проведен клинически и радиографически. Результаты. Bо время операции наиболее частым осложнением была перфорация 
мембраны верхнечелюстной пазухи. Она возникала при вмешательствах на 44 (4,5%) пазухах. Выраженные кровотечения имели место во время 
42 (4,3%) операций. В 22 (2,3%) пазухах у 22 пациентов, из которых 12 были курильщиками, пластический материал инфицировался. В двух 
случаях (0,2%) произошла миграция имплантантов в верхнечелюстную пазуху. Расхождение раны произошло в 13 (1,3%) случаях. Явления 
периимплантaта выявлены у 23 пациентов с 54 имплантами, 8 из них удалены (0,67%). Выводы. Клинические наблюдения подтверждают, 
что поднятие дна верхнечелюстной пазухи с целью улучшения условий для установки зубных имплантатов, является эффективным методом 
с низкой частотой осложнений. Умелый выбор пациентов, правильное планирование лечения и безукоризненное проведение операции c 
применением метода поднятия дна верхнечелюстной пазухи являются необходимыми условиями уменьшения риска возникновения осложнений.
Ключевые слова: дентальная имплантология, поднятие дна верхнечелюстной пазухи, осложнения.
ing the tooth loss an initial buccopalatal reduction of bone 
volume occurs due to the interruption of blood supply to the 
bone plate and the absence of occlusal loads [7-8]. The proc-
ess of resorption takes place in an apical direction and occurs 
together with an increase of sinus pneumatization [9, 10]. As 
a consequence, the sinus floor is located in close proximity to 
the alveolar ridge [11]. Various therapeutic alternatives have 
been proposed to overcome this limitation including lifting 
the vertical bone and sinus floor. However, the maxillary floor 
grafting is a method of attaining sufficient bone height for 
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posterior maxillary implant placement and is regarded as a 
predictable and highly successful procedure. Since it was first 
described by Boyne & James (1980) [12] this technique has 
proven its efficacy and reliability in a variety of clinical cases 
with the usage of different grafting materials and modifica-
tions of the original surgical protocol [13, 14]. This technique 
(lateral sinus floor elevation LSFE) is currently the most com-
mon surgery technique that includes drilling a window in the 
wall of anterolateral maxillary sinus bone and the dissection 
of Schneiderian membrane and the placement of bone graft. 
Implants are placed at the same stage or several months later 
depending on the residual ridge height. Nevertheless, a 
number of less invasive alternative methods of lateral wall 
approaches, such as tilted implants, zygomatic implants, 
pterygoid implants, short implants (less than 10 mm), resto-
rations in cantilever or Summer’s technique (also known as 
osteotomy of sinus floor elevation OSFE), which is routinely 
performed by surgeons when the alveolar ridge height exceeds 
5-6 mm [15], have been indicated. Even a graftless transcrestal 
sinus floor elevation and sometimes a flapless one have been 
described as suitable methods to rehabilitate the posterior 
maxilla with implant-supported prosthesis [6, 17]. The sinus 
lifting is generally considered to be a safe surgical procedure 
with a high success rate unless the complications occur [18, 
19, 20]. The complications related to sinus surgery are rarely 
reported in detail and their effects have been investigated even 
to a lesser extent [22]. The complications associated with the 
procedure and their impact on the implant successfulness and 
survival have been described. The most common surgical 
complication is the perforation of Schneiderian membrane 
which occurs in 7-44% of procedures [23-25]. The most ex-
perienced clinicians estimate their perforation rate to be ap-
proximately 25%. A higher frequency of perforation has been 
reported in smokers. Membrane perforations according to 
the literature are strongly associated with the appearance of 
postoperative complications leading to the acute or chronic 
sinus infections, loss of grafting material and the disruption 
of normal sinus physiology [22, 25]. The perforation should 
be treated immediately to avoid the displacement of the graft 
material into the sinus cavity and subsequent sinusitis. Al-
though Khoury and Proussaefs et al.[24, 26] assume that there 
is a correlation between an implant failure and a sinus mem-
brane perforation, no association between the membrane 
perforation and the implant survival has been found [22, 24]. 
Yet, both anatomical and technical factors have influenced 
the membrane perforation [27]. Sinus septa, a transient mu-
cosa swelling, mucoceles, a narrow sinus, an osteotomy design, 
an increased lateral wall can complicate the membrane eleva-
tion and enhance the risk of perforation during the surgery 
[25, 27-29]. Several attempts have been made to classify the 
membrane perforations. The famous classification has been 
proposed by Vlassis and Fugazzotto [27], who have proposed 
five classes based on the location and the difficulty of repair-
ing [25]. The authors proposed several protocols to repair the 
membrane perforation intraoperatively using a variety of 
techniques and materials, including suturing and the usage 
of a fibrin adhesive [26, 27]. Small perforations usually do not 
need a special treatment because the membrane folds on itself 
during the elevation. A proper understanding of the blood 
supply system of the maxillary sinus can be crucial in many 
instances. An intraoperative bleeding is the result of severing 
or damaging the branches of the vascular supply of the lat-
eral wall of the sinus and the surrounding soft tissue. This 
bleeding is usually minor and of relatively short duration, but 
in some instances it can be profuse and difficult to control in 
time. The bleeding may come either from the soft tissue (ex-
tra osseous branch) during the flap elevation or directly from 
the lateral bone wall (intraosseous branch) during the oste-
otomy of the lateral window, especially with a rotary instru-
mentation. There is also a possibility of bleeding from the 
medial wall of the sinus if the posterior lateral nasal artery is 
damaged. Severe hemorrhages during maxillary sinus grafting 
are rather rare. Small vessels may be broken; if these are lo-
cated in the exposed Schneiderian membrane it is better to 
allow the hemostasis to occur naturally, applying gauze under 
slight pressure. It is not recommended to use an electroco-
agulator which may in fact cause membrane necrosis. The 
displacement of dental implants to adjacent anatomic struc-
tures such as the maxillary sinus is a rare complication but 
may have serious consequences (e.g. sensory disturbance, 
maxillary sinusitis, oroantral fistula). Since the case of implant 
migration inside the sinus cavity was already reported [30], 
other authors have depicted the occurrence of this adverse 
reaction in the maxillary and other paranasal sinuses. Most 
articles include a limited number of implants [30-33] and only 
a few articles include a slightly larger number of cases [34]. 
The migration of such implants in the ethmoid, sphenoid 
sinuses, orbit, nose and anterior cranial fossa is much more 
sporadic [35-37]. The displacement of dental implants during 
sinus surgery can be related to the poor bone quality or quan-
tity, the poor surgical experience of the operator, the presence 
of an uncured perforation, too much implant tapping or the 
application of an excessive force [38]. The lack of implant 
preparation or its displacement or the presence of poor qual-
ity bone that have previously suffered an alveolar infection 
and consequent destruction may cause the implant migration. 
Different theories have been proposed to explain the mecha-
nism by which implants migrate into the sinus, one of them 
being the selection of an inadequate treatment modality to 
rehabilitate the posterior maxilla (e.g. the lack of proper im-
plant site ), which, if not done properly, may lead to this seri-
ous complication [34]. The changes in the intrasinusal and 
nasal pressures [32] are proposed as a primary factor referring 
to this complication. The autoimmune reaction to the peri-
implant bone destruction caused by the implant, which leads 
to the loss of integration, [30] may result in this complication. 
Various treatment modalities from a conservative approach 
(i.e. leaving the migrated implant untreated under a monitor-
ing) [32] to endoscopic transnasal procedures or a conven-
tional Caldwell-Luc technique have been proposed to cure 
this complication. The implant migration into the maxillary 
sinus, which acts as a foreign body, may lead to maxillary 
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sinusitis and a chronic infection or the patient may remain 
asymptomatic. Rhino sinusitis, a well-known complication 
associated to the sinus lifting procedure [39, 40], is considered 
a major but infrequent complication requiring an urgent 
treatment in order to prevent some more serious complica-
tions, as the infection can spread throughout the graft and the 
sinus cavity or the adjacent anatomical structures and cause 
a life threatening risk [41]. Soft inflammatory mucosal 
changes do occur immediately after the operation. According 
to the literature, acute postoperative sinusitis occurs as a 
complication in up to 4.7% of sinus graft procedures [42]. 
Most often the infection appears after more than one week 
after the surgery. This disorder should be taken into consid-
eration if the patient postoperatively complains of any of the 
following symptoms: headache, tenderness pain in the area 
of the maxillary sinus and rhinorrhea. The studies have sup-
ported the fact that the patients who have predisposing factors 
for sinusitis are more at risk of developing postoperative 
transient sinusitis. The wide range of reported percentages 
(3% to 20%) may be the result of different methods used for 
the diagnosing (i.e. clinical, radiographic, endoscopic). To 
date, in the modern literature no general treatment protocol 
for sinus graft infections that has been followed and evalu-
ated in serial cases is described [43].
It is difficult to treat infected sinus grafts as the graft itself 
lies within the sinus cavity underneath the elevated sinus 
membrane. Yet, the previous experience in treating sinus 
graft infections with antibiotics usually has not resulted in 
the elimination of the graft infection, and a further complete 
graft removal has been necessary. Urban and colleagues [43] 
have described a treatment modality with the usage of surgical 
and pharmacological protocol to treat the sinus graft infection 
complication that salvages the graft and does not necessitate 
a complete removal of the graft. Mahler et al. [44] have re-
ported a new “dome phenomenon” which has been observed 
in the infected lifted sinuses. The patients have undergone a 
surgical debridement followed by a complete healing. They 
have observed a dome of dense, solid material which has been 
located in the most superior place of the grafted area. Antral 
septum is the most common osseous anatomical variant seen 
in the maxillary sinus [5]. The prevalence of septa has been 
reported to be as much as 22% in the edentulous patient. The 
septa may be complete or incomplete on the floor, depending 
on whether they divide the bottom of the sinuses into sections. 
The sinus septa may create an extra difficulty at the time of 
surgery causing the membrane perforation. The wound de-
hiscence or the incision line opening occurs more commonly 
when a horizontal-ridge lifting is performed at the same time 
as a sinus graft surgery, or when the implants are placed above 
the residual crest and covered with the soft tissue. It may also 
occur when a soft tissue-supported prosthesis compresses the 
surgical area during its functioning before the suture removal. 
The consequences of the incision line opening are: a delayed 
healing, the leaking of the graft into the oral cavity and an 
increased risk of infection [46]. Overfilling the sinus can result 
in the blockage of the ostium, especially if the membrane in-
flammation or the presence of thickened sinus mucosa exists. 
The majority of sinus graft overfills do not have postoperative 
complications. If however, a postoperative sinus infection oc-
curs without the initial resolution, the reentry and removal 
of a portion of the graft and changing the antibiotic protocol 
may be appropriate [46]. Postoperative maxillary surgical 
cysts have also been reported in the literature after the sinus 
graft surgery, however, they are extremely rare. In 1991 Misch 
et al. [45] reported one incidence of maxillary surgical cysts 
associated with the past sinus graft and blade implant. The 
complete enucleation was accomplished, and the healing was 
uneventful. The occurrence of a postoperative maxillary cyst 
following the sinus grafting is exceptionally rare. Usually the 
cyst is asymptomatic. The removal of the implants and the cyst 
is indispensable with the following re-grafting of the created 
empty space. The aim of the present study is to evaluate the 
complications associated with the maxillary sinus lifting and 
their impact on the subsequent implant treatment. In addition, 
this study is aimed to identify the factors that may contribute 
to the occurrence of those complications and suggest different 
therapeutic approaches to resolve them.
Material and methods
Patients
Within a 15-year period (1997-2012) 685 generally healthy 
patients, 318 males and 367 females, aged from 22 to 82 (av-
erage age 58.5), who have had partially or totally edentulous 
maxilla associated with various degrees of alveolar ridge 
atrophy and sinus pneumatization that have not allowed the 
placement of standard implants, have been selected for the 
surgical treatment of the bone deficiency to allow implant 
placement for fixed implant supported prosthesis. The patients 
have been initially examined and evaluated for the data col-
lection, this has included:
a) A general health status;
b) The analysis of the oral status including inter-arch 
relationship and natural residual dentition of the op-
posite arch;
c) A radiographic evaluation with panoramic radiograph 
and CT-scans;
d) Dental study casts and a wax-up;
e) An informed consent before the beginning of the treat-
ment after giving the information about the treatment 
plan, including risks and complications of the treat-
ment, which may occur as well as the potential benefits, 
and alternative treatment procedures.
A total of 1184 implants have been consecutively placed 
for restoration of partially edentulous sites or a single tooth of 
the posterior maxilla. Table 1 shows the patients distribution 
related to the gender and age.
It has been mandatory to thoroughly review the patients’ 
medical history. A special attention has been paid to the 
patient related factors that might affect a bone healing prior 
to determining the suitability of a patient for this kind of 
procedures. All the patients have met the requirements of a 
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strict selection protocol (tab. 2).
Table 2
Criteria Used for the Patient Selection
Inclusion
 Presence of at least 1 mm residual bone height (RBH)
 Good general health and patients with controlled health 
condition
 Stable mental health condition
 Ability to complete at least 24 months of clinical follow-
up
 Willingness to provide a signed informed consent
Exclusion
 Uncontrolled diabetes
 Evidence of sinus pathology e.g., chronic or acute sinusi-
tis, cysts, tumours
 Presence of immunodeficiency
 Taking immunosuppressants
 Taking bisphosphonates
 Radiation therapy on the head and neck including maxilla
 Chemotherapy during 12-months period prior to the 
proposed therapy
 Heavy smokers – more than 20 cigarettes a day
The candidates for sinus floor elevation (SFE) who have 
presented any condition that would affect the bone healing, 
either locally or systemically have been rejected. All the pa-
tients have been selected according to the specific inclusion 
criteria: an edentulous posterior maxilla, the posterior residual 
height at least 1mm to the sinus floor and no diagnosed bone 
disease or medication known to affect the bone metabolism. 
The patients have been in particular tested for seasonal aller-
gies, allergic rhinitis or a sinus congestion, all of which may 
indicate a potential sinus pathosis. A patient with sinusitis, 
a sinus disease or invasive lesions has been referred to an 
ear-nose-throat (ENT) specialist for the treatment before 
the surgery. The current standard for radiographic imaging 
to identify a sinus disease is the CT scanning. All the patients 
have been clinically free of any pathology in the maxillary 
sinus. The individuals have been included in this study if they 
have been medically able to withstand the procedures and have 
possessed the insufficient residual bone to allow the placement 
of standard implants, and could receive the reconstructive 
procedures. The known factors that may influence the healing 
process of the bone graft, such as a general health condition, 
a current medication and tobacco smoking have been docu-
mented. The tobacco taking has not been considered as an 
absolute contraindication for the SFE procedure. It has been 
mandatory to inform those patients about the increased risk 
of the implant loss and a peri-implant bone infection. They 
have been motivated to refrain from or at least reduce their 
smoking habits. The patients with any kind of abuse problems 
have been examined carefully. In many cases, some alterna-
tives to implant therapy including the SFE procedure have 
been preferred. 125 patients have stated that they smoke 1 to 
10 cigarettes a day, and those smoking more than 10 cigarettes 
per day have been asked to stop smoking before the surgery.
After a detailed clinical and radiographic examination all 
the patients have been given the detailed information about 
two treatment options:
– a sinus grafting procedure by lateral access with a simul-
taneous implant placement;
– a sinus grafting procedure by lateral access with a delayed 
implant placement.
586 patients have had partially edentulous maxilla (394 – 
unilateral, 192 – bilateral) and 99 patients – totally edentulous 
maxilla. Of the latter, 94 patients have presented a bilateral 
deficiency and 5 patients – a unilateral deficiency. The residual 
alveolar ridge height and width have been measured clinically 
by caliber and radio graphically using the panoramic radio-
graphs and CT-scans. The preoperative CT scans have not 
managed to be made for all the patients since the CT scans 
are expensive and are difficult to access at the time many of 
these patients are treated. A residual height of 4 mm has been 
arbitrarily chosen as a “cut-off ” measurement to determine 
the kind of surgical technique. If this has corresponded to the 
adequate bone width of at least 5 mm and adequate bone qual-
ity, these can be considered sufficient to provide the primary 
stability of the implants placed simultaneously by means of 
the sinus grafting procedure. Whereas there have been lower 
values (4 mm), generally, the elevation of the sinus with 6 
months delayed implantation after this procedure has been 
needed. The appraisal of bone quality has been performed 
according to the classification of Lekhonm and Zarb [47]. The 
stability of the implant has been evaluated objectively by the 
application of torque and perio-test measurement (Gulden, 
Laurrtal, Germany). The length of the implant has been used 
as a reference for the measurement of the peri-implant bone 




Distribution of Patients with Regard to Gender and Age
 Age
Gender < 20 21-30 31-40 41-50 51-60 61-70 > 71 Total
Female 36 38 37 76 78 64 38 367
Male 32 35 36 66 63 53 33 318
Total 68 73 73 142 141 117 71 685
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Two different grafting materials have been used: depro-
teinized bovine bone material (DBBM, Bio-oss, Geistlich 
Pharma, Wolhusen, Switzerland) and β-Tricalcium-phosphat, 
cerasorb (Curasan, Kleinostheim, Germany). The above have 
been employed as particulate grafting materials beneath 
resorbable collagen membrane (Epi-Gide, Geistlich Pharma, 
Wolhusen, Switzerland). The research patients have been 
divided into 4 groups according to the material used for the 
sinus lifting.
For 125 patients in β-Tricalcium phosphate group (T) 
β-Tricalcium phosphate has been used in the form of cerasorb 
sized 1000 to 2000 mm. For 108 patients in β-Tricalcium 
phosphate + autogenous bone group (TA) β-Tricalcium phos-
phate mixed with the autogenous bone taken from the same 
surgical sites of the maxillary tuberosity has been used. The 
autogenous bone has been harvested using bone scrubbers and 
combined with β-Tricalcium phosphate, which has made up 
50% of the mixture. For the next 285 patients only deprotein-
ized bovine bone has been used, Bio-oss spongiosa type, with 
a particle size 1 to 2 mm. For 167 patients in the group using 
deproteinized bovine bone + autogenous bone (DA) 50 % of 
autogenous bone has been added to the deproteinized bone 
substitute like in group TA. During the surgical procedures 
all the combinations of graft materials have been mixed with 
patients’ blood taken from the operation site. The authors have 
chosen to study β-tricalcium phosphate (β-TCP) for the sinus 
grafting. This allopast is a derivate of hydroxyapatite, which is 
the mineral or inorganic component of bone. Hydroxyapatite 
is nonresorbable and acts as a scaffold for osteoconduction. As 
it lacks the growth factors, it has no osteoinductive properties, 
however, it does have osteoconductive properties. Among 
the xenografts, the natural bone material Bio-Oss (Geistlich 
Pharma, Wolhusen, Switzerland) has shown excellent osteo-
conductive properties and promising results in sinus floor 
elevation procedures.
Implant systems and characteristics
Titanium screw implants of 3.3, 3.75, 4.2 or 5 mm in 
diameter and of various lengths – 8, 10, 11.5, 13 and 16 mm, 
with internal hexagonal legs from Alpha Bio tech, MIS, Alpha 
Gate, Adin Israel have been used for all the patients.
Surgical technique
A total of 971 sinus grafting procedures with simultaneous 
and delayed implant placement using a window technique 
have been performed. All the patients have been subjected to 
the prophylactic antibiotic coverage. The patients have orally 
received 1.5 g clavulanate-potentiated amoxicillin (Augmentin 
875 g) 1 hour before the surgical procedure; the penicillin 
allergic patients have received 450 mg clindamycin, which 
continued for 10 days of post surgery period. Immediately 
before the surgery, the patients have undergone a 3-minute 
mouth rinse with 0.2 % chlorhexidine gluconate. After the 
anesthesia by 2% Lidocaine with 1:100000 epinephrine a 
crested incision, slightly off the palatine level, has been made 
through the entire length of the edentulous area. At the level 
of the proximal aspect of the tooth that has mesially bordered 
the edentulous area an anterior releasing incision has been 
made. Posteriorly, the releasing incision has been located in 
front of the tuberosity. A full thickness flap has been reflected 
to expose the lateral wall of the sinus. The mucoperiosteal 
flap has been reflected superiorly to the level of the molar 
buttress to expose the complete lateral wall of the maxilla. 
The elevation of the periosteum adjacent to the implant site 
has been minimized to preserve a blood supply to the alveolar 
crest. The periosteom has been reflected superiorly to the 
anticipated height of the lateral maxillary wall in fracturing. 
The soft tissues, overlying the cortical bone of the buccofacial 
wall of the maxillary sinuses, have been removed entirely to 
expose the bone surface in the required area. The antrostomy 
has been outlined with a 5 or 6 round bur in a straight hand 
piece at 2000 rpm under a copious external irrigation. Once 
the access has been delineated, the bur has been used to 
continue outlining the osteotomy until a bluish hue has been 
observed all around the access windows, indicating the closely 
underlying Schneiderian membrane. It has been obligatory 
to estimate the thickness of the buccofacial wall of the max-
illary sinus to minimize the occurrence of a mucoperiosteal 
perforation during the antrotomy. The extra precautions 
have been required for the thick buccofacial wall to keep the 
mucoperiosteum of the sinus wall intact. To make sure that 
the outlined bone has been penetrated, it has been tapped 
gently all around the osteotomy with a blunt instrument until 
a movement has been visible, creating a rectangular window 
with rounded or elliptically shaped angles, ensuring that the 
inferior border is at least 2 to 3 mm superior to the sinus floor. 
The out fracture osteotomy or “off-the-wall” technique for 
sinus grafts, in which the complete 360 – degree osteotomy 
is performed, has been used. This opening is measured on 
average 6 mm in vertical dimension and 15 mm in the me-
siodistal dimension. The location of the lateral window and 
its size affect the clinician’s ability to elevate the membrane 
safely. The anterior portion of the sinus can be very narrow, 
requiring the coordination and vision possibility to prevent 
the membrane perforation. The ideal location for the window 
has been defined 3 mm superior to the sinus floor and 3 mm 
distal to the sloping anterior wall. The care has been taken of 
the sharp edges of an elevated bone window which may cause 
a laceration of the membrane. When bone scrapers were used 
to perform the lateral antrostomy, the lateral wall of the sinus 
was scraped and by itself provided the autogenous bone grafts. 
Working directly against the membrane has been avoided to 
decrease the risk of the membrane perforation. In twelve cases 
a discontinuity of the lateral wall has been known to exist 
as a result of an aggressive extraction, therefore a thickness 
flap dissection over the site has been performed to avoid a 
laceration of the sinus membrane. Once the lateral window 
was created, the sinus membrane was carefully peeled off the 
sinus floor and medial sinus wall until it became completely 
detached from the lateral and inferior walls of the sinuses, and 
the compartment for grafting material was created. Once there 
was a sufficient exposure, the membrane was examined for 
perforations. If no visible perforations have been observed, 
the space has been filled with saline, and the patient has been 
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asked to gently perform Valsalva maneuver. Air bubbles have 
indicated the presence of the perforation. The overlapping re-
sorbable collagen membrane (Bio-Gide, Geistlich, Wolhusen, 
Switzerland) has been used to repair the perforations. After 
the sinus membrane has been elevated until it has become 
completely detached from the lateral and inferior walls of 
the sinus, the preparation of the implant sites has been un-
dertaken in case the simultaneous implantation was planned. 
The implant sites have been marked using a surgical template 
and then drilled in the required areas. After filling the graft-
ing material, the fenestrated lateral wall of the maxillary sinus 
has been covered with a resorbable collagen membrane, and 
the mucoperiosteal flap has been repositioned and sutured.
Results
A total of 685 patients (367 female and 318 male) have 
been treated. They have received 1184 implants and 971 
sinuses have been elevated in one and two stage surgery. 399 
unilateral (206 right and 193 left maxillary sinuses) and 286 
bilateral sinus elevation procedures have been performed. The 
surgery has been carried out by the same surgeon. Normal 
clinical healing has occurred in most patients and has been 
characterized by maintaining the postoperative swelling 
for 48 hours that has decreased gradually and disappeared 
completely after 10 days. Any discomfort has been primarily 
associated with tension from the swelling or haematomas. The 
postoperative recovery has been uneventful in 923 out of 971 
reconstructive procedure cases (95%). The healing period fol-
lowing the 923 procedures of sinus lifting has passed without 
complications. Minor nasal bleedings occurred in 120 cases. 
125 patients have claimed to be light smokers (less than 10 
cigarettes a day). Although they all were informed about the 
negative effects of smoking on bone regeneration, none of 
them has stopped their habits.
1122 of 1184 inserted implants have resulted to be osseo 
integrated after 5 years of prosthetic loading (cumulative sur-
vival rate 94.7%). In this study, the RBH has ben 1-2 mm for 
23.5% of the placed implants, 2-4 mm for 49.0% of the placed 
implants and 4-6 mm for 27.5% of the placed implants. The 
bone resorption has been mainly seen apically, but in some 
cases – also marginally.
Implants survival and success rates
The average follow-up period of implants lasting after the 
beginning of prosthetic loading has been 59 months. Out of 
1184 implants placed in grafted sinuses, 23 implants in 10 
patients have been removed due to the loss of integration, 
untreatable peri-implantitis or chronic pain. Of these, 8 have 
been removed before the abutment connection, while 15 have 
been removed after the start of prosthetic loading. A total of 
additional 12 implants in 12 sinuses have failed to integrate 
prior to uncovering, and those have been removed by the 
second-stage surgery. Five of them have been successfully 
replaced with larger diameter implants (5 mm) at the time of 
their removal without any additional bone grafting; another 
16 implants were lost between the second stage surgery and 
the first year follow-up examination. 
Totally 11 implants were lost between the third and fifth 
following years. For the failed implants the pre-surgical height 
was respectively 4 and 5 mm and the implant diameter was 
3.75, 4.2 mm, and a perio-test value was -5 and -4. These im-
plants have been substituted by the 5.0 mm diameter implants 
at the same surgical stage and restored after an additional 
three months healing.
Eighteen implants placed in the grafted sinus, although 
still in function, have not answered the success criteria due 
to the peri-implant bone resorption rates higher than those 
proposed for the successful implants [1]. The overall survival 
and success rates of implants placed in grafted sinus have been 
97.8% and 94.7%.
The main cause of implant failure (67.2%, n = 42) has been 
infection followed by the loss of integration (12.8%) (n = 8) 
and severe bone loss (20%, n = 12). The bone loss because of 
the infection has also been reported.
A total of 162 single implants have been placed in 123 
patients in isolated grafted maxillary sinus sites. All the im-
plants placed have had the length of at least 11.1 and 13 mm 
to achieve an implant-crown ratio ≥ 1.0.
The followed peri-implant conditions such as radiographic 
marginal bone resorption, pocket depth and perio-test values 
of all the implants evaluated at the last examination have been 
recorded.
The residual ridge height has ranged between 1 and 6 mm. 
The mean RBH has been 4.8 mm.
All the patients included in the study have fulfilled the 
follow-up. 288 patients were followed for 5 years, 210 – for 
4 years and 187 – for 3 years. Xenograft (DBBM Bio-Oss, 
Gestlich Pharma) has been the most frequently used graft-
ing material (22.5% of cases). It has been used in both large 
(39.4% of cases) and small (47.0% of cases) granules or in 
combination of the both (13.5% of cases). Autogenous bone 
in combination with DBBM and β-TCP has been used in 9.5% 
and 5.0% of cases respectively. Another bone substitution, 
β-TCP alone, has been used in 13% of cases after SFE surgery; 
here the patients have reported only a moderate discomfort 
in the surgical sites during the first week of healing. All the 
patients with fixed prostheses have been rehabilitated. The 
implant surgery procedure has been performed in two stages 
after 6 months healing by insertion of a single implant or 2 to 
4 implants in unilateral cases.
The postoperative examination after the bone graft pro-
cedure has showed an available bone height of the edentulous 
regions measured from the crest to the superior part of the graft 
14.2 mm on the right side and 13.8 mm graft on the left side.
Of the implants placed after graft consolidation 38.0% 
have been placed by a single stage procedure and 62% have 
been placed by a two-stage procedure.
The perio-test values for the evaluated implants at 6th and 
12th months examination ranged from -7 to +5 and every 
time the values decreased, ranging from -8 to +3 for the 1184 
implants evaluated at the 5th year examination. To summa-
rize the clinical and radiographic results, all remaining 1122 
implants were considered successfully integrated at the 5th 
year examination. With respect to the given procedure, 953 
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implants (80.5%) have been placed in grafted sinuses without 
any other associated procedures, 142 implants (12.5%) have 
been placed in sinus lifted regions along with horizontal bone 
grafts, and 89 implants (7.5 %) have been placed in the sinuses 
by cortical split technique. The five-year implant survival rate 
for these groups have been 94.6%, 93.1% and 91.0% respec-
tively. Clinically all 1122 followed implants have showed no 
signs of major peri-implant infection or detectable mobility 
throughout the healing period. All the implants have exhibited 
the preferable position, which allowed the abutment connec-
tion to the implant for the further prosthetic rehabilitation.
Intraoperative complications
Intraoperative Bleeding
Vascular bleeding has been observed in 52 sinus elevation 
procedures. In these clinical cases a number of techniques to 
control the vascular bleeding have been used – electro-cautery 
and the use of a vasoconstrictor (1:50000 epinephrine) for con-
trolling the soft tissue bleeding that occurs in some cases while 
releasing incisions before the elevation of the mucoperiosteal 
flap are made. A care was taken not to damage Schneiderien 
membrane by the electro-cautery.
If the bleeding has occurred from intraosseous vessels, 
crushing the bleeding channel to compress the bone and ves-
sel has been made to stop the bleeding. Because of the small 
size of the artery the bleeding has been usually controlled by 
pressing it with a gauze pad for several minutes resulting in 
a clot formation within the bone channel around the artery. 
We have been especially concerned about finding a possible 
compromise regarding the vessel because of the large size of 
the intraosseous artery for fourteen young patients (30-35 
years old). In those young patients the incidence of bleeding 
has been reduced by performing the osteotomy of lateral 
window not to the full height due to the location of the in-
traosseous artery.
Schneiderian membrane perforation
In 44 sinuses, where the sinus membrane has been torn or 
perforated (fig. 1), the fragility of the remaining membrane 
has been increased, and care and delicacy has been required 
to complete the elevation. The perforated membrane has been 
elevated around the perforation site carefully from the floor, 
medial and anterior bony walls to allow the blood supply from 
the bony walls to vascularize the graft, and a resorbable col-
lagen membrane (Bio-Gide; Geistlich, Wohlusen, Swizerland) 
has been placed over the area to facilitate the sinus membrane 
dissection and elevation. In 18 patients small perforations of 
the sinus membrane have not been treated, as these defects 
have been closed by folding of the lifted membrane or a self-
repair with a small blood clot has been accomplished. To avoid 
the shifting tendency we have used a large membrane (20 x 
30 mm size) and left a portion of it outside the folding on the 
lateral wall in superior direction. A total of 224 implants have 
been placed in the sinus perforated cases. Fourteen failures 
have occurred in the given cases. The implants have been re-
moved prior to the loading. In these cases the areas have been 
re-augmented and the implants have been placed after addi-
tional 6 months of healing. In 16 cases where the septa have 
been the lateral window has been lengthened in the anterior 
and posterior directions so that the window has been located 
both anterior and posterior to the septum. This has allowed 
the membrane elevating from the both sides of the septum, 
and it has been impossible to elevate the membrane from a 
septum without perforating it. In 26 cases a large membrane 
perforation has been observed after unsuccessful repair and 
suturing. The repair has been accomplished according to the 
technique introduced by Proussaefs and Lozada [24] to repair 
extra large perforated membrane. The collagen membrane 
surrounds the graft material and seals the lateral access win-
dow. In no case it has been necessary to cancel the grafting 
procedure and subject the sinus membrane to healing. The 
grafted material has been placed against the medial wall, and 
implants have been placed by means of the surgical procedure 
according to the manufacturer’s protocols. It has been critical 
to accomplish the primary stability for the residual bone and 
for the remainder of the graft material to fulfill the compart-
ment to the contour of the lateral wall. A bio absorbable 
membrane has been used to close the lateral wall. There have 
been 5 punctual lesions, which have not required any special 
treatment. These perforations have been classified according 
to the simplified classification of the membrane perforation 
made by Fuguzzotto and Vlassis [27].
After the sinus floor elevation with perforation one dehis-
cence of the gingival wound has taken place, the fact that has 
extended the healing time but has caused no further graft or 
implant loss as there has been no connection to Schneiderian 
membrane.
Migration of implants into the maxillary sinus
In our research in 2 cases dental implants have displaced 
into the maxillary sinus cavity. One of them was displaced 
at the time of surgery and the other migrated several years 
after the placement due to a spontaneous implant loss (fig. 2). 
Case 1: A 53-year-old woman has been referred to our private 
practice to undergo the sinus elevation with simultaneous 
implantation. While being inserted during the surgery the 
dental implant was displaced into the sinus lumen. A pano-
ramic radiograph has revealed the presence of the implant 
within the superior region of the maxillary sinus. The maxil-
lary sinus has been carefully inspected until the migrated 
implant could be visible and removed. This manipulation 
is not questioning the completion of the surgical procedure 
as planned. Case 2: A 56 year-old woman has undergone 
the grafting with simultaneous implantation of 3 implants 
in the right sinus. No complications have occurred during 
the surgery. The implants have been considered to be stable 
at the surgery time. Prior to the second-stage surgery the 
panoramic radiograph has detected a displacement of the 
implant into the right maxillary sinus. The patient has been in 
a good health state and had no sinus complains. A thorough 
history, clinical and radiographic examinations including the 
CT scan have revealed neither history nor actual sign of sinus 
related pathology. The implant has been located in the region 
of the ostium. The patient has been prepared for the implant 
removal. To remove the implant in the right maxillary sinus, 
the lateral wall of the sinus has been fenestrated with a round 
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bur; a care has been taken to preserve as much grafting mate-
rial as possible. A small part of the placed grafting material 
has been removed to reach the raised sinus membrane. A one 
cm incision has been made through the membrane and the 
inspection of the maxillary sinus has been performed. There-
after, the implant has been visible and could be removed with 
forceps. The perforation site in the sinus membrane has been 
sutured with vicryl (Ethicon, Germany) and covered with 
absorbable collagen membrane (Bio-Gide). After grafting the 
space underneath the sutured membrane the mucoperiostal 
flap has been repositioned and sutured with monofilament. 
The postoperative period has been uneventful. The patient 
has received a broad spectrum antibiotic and a nasal decon-
gestant for one week and has been instructed to use a 0.2% 
chlorhexidine mouth rinse for 2 weeks. No complication has 
been observed postoperatively. Four months after the second 





Fig. 2. Implant migrated into the maxillary sinus.
Fig. 4. CT scan showed a radiolucent area in the center of the grafted area with a cloud-shaped  
radiopacity at the most superior border of the sinus cavity.
CBA D
Fig. 3. Formation of a fistulous tract (a), infected grafted area (b, c, d).
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bone grafting and implant removal the bone consolidation 
has seemed to be sufficient for the placement of an implant. 
Three months after the prosthesis has been made and during 
the follow-up period of 5 years no maxillary sinus complains 
have been noted and no implants have been lost.
“Dome phenomenon”
The “dome phenomenon” has been observed in infected 
lifted sinuses of one patient. A 56 year-old man has under-
gone the sinus lifting with simultaneous implant placement. 
The sinus has been grafted with DBBM (Bio-oss, Geistlich, 
Swizerland) and covered with collagen membrane (Bio-Guide, 
Geistlich, Swizerland). Schneiderian membrane has been in-
tact. The patient has received antibiotics (Augmentin 875 mg) 
for 10 days and has been instructed to use the mouth rinse of 
0.2 chlorhexidine. Four weeks postoperatively, suppuration 
with fistulous tract into the oral cavity (fig. 3A) has been seen 
as well as a facial swelling, a severe pain, an abscess and a loss 
of graft particles through the fistula. The additional antibiotics 
have been prescribed: 1.5 g/d Amoxicillin clavulanate (Aug-
mentin 875 mg, Smithkline, Beecham, Brentford, Fliddlesex) 
and 1 g Metronidazole (Haupt pharma, Livron-Sur-Drome, 
France). After 10 days the clinical symptoms have improved 
and the pain has subsided. Four months postoperatively the 
patient has appeared with an acute abscess along with facial 
swelling at the surgery site. The obtained panoramic radio-
graph has showed the loss of integration of one implant. The 
infected area has been treated surgically and the implant has 
been removed along with the inflammatory tissue by means of 
granulation. The superior border of the lifted sinus has been 
intact with dense, solid tissue separating the remaining defect 
from the sinus cavity (fig. 3B, 3C, 3D). It has appeared that the 
infection did not yet covered the entire graft. Post operation 
panoramic radiograph has showed the radiopaque dome at the 
most superior border of the lifted sinus. After treating the in-
fection the acute symptoms have disappeared within 48 hours, 
and the patient’s healing has gone uneventfully afterwards. The 
total healing time prior to the implant placement has been 7 
months for this patient. After the healing period the defect has 
demonstrated a bone fill and has greatly reduced in size. The 
CT (fig. 4) scan has showed a radiolucent area in the center of 
the grafted area with a cloud-shaped radiopacity at the most 
superior border to the sinus cavity. New implants have been 
inserted and the gap has been filled with additional DBBM 
(Bio-oss). No further complication has been evident. The 
implants have been loaded four months after the placement 
and are still in function 5 years after the operation.
Deprotienized bovine bone (Bio-oss, Geistlich) and fully 
synthetic ceramic graft material (cerasorb, Curasans, Klei-
nostheim, Germany) within 100 to 400 µm particle size have 
been used in all the cases.
Postoperative complications
Sinus graft infection
In the postoperative period twenty two patients have ex-
perienced varying degrees of sinusitis symptoms from thicke-
ning the sinus mucosa to a purulent infection. One or more 
clinical symptoms of sinus graft infection they experienced 
between the first and fourth weeks after the sinus elevation 
were the following: an abscess, a severe pain, a recurrent facial 
swelling, a fistulous tract extending into the oral cavity, a loss 
of graft particles through the fistula or through the borders 
of the flap (“popcorn sign”). A postoperative CT scan has 
been performed for all the patients to evaluate the involve-
ment of the sinus lumen. Thirteen patients have showed the 
sinus involvement according to the performed CT scans. Six 
patients have showed thickening of the sinus membrane and 
two patients have showed a complete pacification of the sinus 
cavity. Thirteen patients have developed an acute infection 
in the operated right maxillary sinus. After the treatment 
by antibiotics (Augmentin 875 twice a day) the site has been 
incised and drained under the local anaesthesia.
The last patient experienced a severe pain 1 to 2 weeks 
after the surgery which has disappeared later. No additional 
clinical symptoms occurred in this patient for 5 weeks, then 
the patient has had a high temperature and a recurrent facial 
swelling without an intraoral fistula, and this time a surgical 
intervention has been considered necessary. A combined 
treatment regime for sinus graft infection has been per-
formed – both the surgical intervention to treat the infected 
graft material and the systematic pharmacologic treatment 
for the infection. All sinus graft infections have been treated 
locally with the same surgical approach. The full-thickness 
flap from the performed sinus floor elevation procedure has 
been re-elevated to expose the bone graft. Any loose grayish-
looking graft particles floating on the purulent exudates and 
any loose membrane pieces have been removed and the site 
has been irrigated with a sterile saline, until a more confined, 
intact, stable, immature, healthy looking graft material has 
been visible. It has appeared that the infection did not involve 
the entire graft. A subjective decision is to determine which 
graft zone is not subjected to the infection. A locally applied 
antibiotic has been used empirically to treat the remainder of 
the sinus graft and reduce the risk of the persistent infection. 
100 to 200 mg of doxycycline powder with saline has been 
placed in the bone graft for two minutes and then has been 
washed out with a sterile saline. To ensure the formation of 
a blood clot the defected place has been gently curetted to 
establish bleeding of the area resulting in a five-wall defect 
within the sinus graft and preserving the elevated sinus. The 
flap has been closed and sutured for a primary closure. There 
has been no the detectable communication between the 
defect and the sinus cavity in the patients including the two 
patients who have had a concomitant sinusitis. All the patients 
have received a systemic medication to prevent the infection 
spreading throughout the remaining graft and the sinus or 
other adjacent vital anatomic structures. A systemic antibiotic 
(Augmentin 875 mg, twice a day) and an anti-inflammatory 
medication (50 mg diclofenac potassium three times a day) 
have been administered for 1 week following the surgery. A 
nasal decongestant spray has been used three times a day 
for four days by the patients with concomitant sinusitis. The 
total healing time prior to the implant placement has been 
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extended to allow a new bone formation in the 5–wall defect 
area. Any remaining bone deficiencies have been grafted 
after the time of the implant placement. In 5 procedures the 
graft infection has occurred despite the absence of clinically 
detectable dehiscence and the graft has had to be partially or 
totally removed. Nevertheless, in 3 patients it has been still 
possible to complete the prosthetic rehabilitation by modify-
ing the dimension, position and/or number of the originally 
placed implants, while only in 2 patients, due to the total loss 
of grafted bone, the implant placement has been impossible.
Wound dehiscence
The dehiscence of the surgical wound has occurred in 3 
patients treated with sinus grafting along with guided horizon-
tal bone regeneration. In 3 patients the exposed bone graft has 
been treated only with cautious curettage, antibiotic therapy, 
chlorohexidine gel and spontaneous healing by secondary 
intention. No clinical signs of infection have been found in 
2 patients and the patients have been rehabilitated with the 
implants according to the pre-operative plan. The implants 
have undergone a normal integration and it has been possible 
to complete the prosthetic rehabilitation successfully. In one 
patient the infection has occurred despite this treatment and 
the graft has had to be partially removed until a spontaneous 
healing has been completed.
Peri-implant infection
The follow-up examination has revealed that 54 implants 
in 23 patients have developed local peri-implant infections. 
Local irrigation of the peri-implant sulcus with chlorhexidine 
diglucanate 0.2 % twice a day for two weeks has been initi-
ated, and then the implants have been subjected to the open 
flap surgery. The peri-implant infection has been successfully 
treated. In 5 patients 8 implants have been surgically removed 
12 months later because of increasing pain in the peri-implant 
region. The patients have reported a slight improvement of 
the state.
Atypical facial pain
One patient (a female of 39 years old) has experienced an 
unexplained facial pain in the right maxilla after the sinus 
grafting and delayed insertion of 3 implants. The pain has 
started a few weeks after the implant placement. No clear 
cause for the pain could be defined even after consulting an 
ear, nose and throat (ENT) specialist and a neurologist. The 
diagnosis has been “atypical facial pain”. The implants have 
been removed later. The patient has reported a subsidence of 
the pain after a short period of time.
Discussion
Maxillary sinus floor elevation and grafting with biomate-
rial via a lateral approach is a safe and predictable procedure, 
which also allows implant placement in severely resorbed 
posterior maxillae. Multiple modifications of the original sinus 
lifting technique [12] have been proposed, which comprise a 
variety of biomaterials [46] and techniques [47, 48]. All the 
approaches have demonstrated a high predictability, regardless 
of the grafting material employed on condition that they are 
applied following an evidence-based approach [13, 14, 49]. 
If the residual bone volume is more than 5 mm in height the 
primary stability of the implants can usually be achieved [50] 
and it has also been our experience if there has been less than 
5 mm of available residual bone. A two-step procedure has 
been recommended. The possibility of placing all the implants 
in one-stage is advantageous for the patient as it reduces the 
number of the procedures and the time needed to complete 
the prosthetics. Regardless of the surgery procedures still 
some problems can exist, ranging from discomfort to other 
complications in the sinus cavity [22, 39, 42, 45, 51, 52].
The most commonly reported intraoperative complication 
of sinus lifting is a membrane perforation [22-25, 27]. It has 
been reported to occur in 7-35% of sinus floor elevation proce-
dures [6, 22, 25, 26]. In the present study the rate of membrane 
perforation has been 4.5%. The reported complication rates 
vary considerably. They start with 12% in the study of 965 
sinus floor elevations reviewed retrospectively. The common 
rates of a meta-analysis are 18.4 %. Two other studies have 
described values of 6 perforations in 30 operations (20%) and 
51 out of 216 cases (23.6%). The highest value in the litera-
ture is 36 out of 81 (44%) [22]. Our complication rate is the 
lowest of the reported rates. Schneiderian membrane on the 
whole contributes to an adequate graft healing, probably due 
to its high reparative potential [53]. This factor is essential to 
maintain the sinus cavity isolated from grafting material and 
implants. The 45 sinuses with membrane perforation have 
not shown any significant complications during the healing 
period or at the time of implant placement. On the contrary, 
other authors [24] have suggested that a sinus membrane per-
foration larger than 2 mm could be associated with reduced 
bone formation and a successful management of the implant 
compared to the sinus without a membrane perforation. To 
explain this fact it can be hypothesized that the displacement 
of a biomaterial through the sinus membrane can lead to 
transient or chronic sinusitis in 10% to 20 % of sinus elevation 
cases [51] and, thus, question the implant survival. Dislocated 
bone particles may also initiate a local inflammation and 
subsequent severe resorption of the bone graft [24]. Aimetti 
et al. [54] have observed that the presence of free moving 
alien bodies may lead to the initial phlogosis of the mucosa 
with edema and progressive obstruction of the nasosinus 
osteum leading to the reduced ventilation and mucociliary 
clearance. Several authors have recommended the usage of a 
resorbable collagen membrane for the sinus membrane repair 
[24], expecting it to seal the perforated membrane. Vlassis 
and Fugazzotto have introduced a classification for the per-
forated sinus membrane based on the location and difficulty 
to repair. A recent study has found out that the survival rates 
of implants placed under reconstructed membranes correlate 
inversely with the size of the perforation [55]. On the contrary, 
Schwartz-Arad et al. [22] have found no correlation between 
postoperative complications of the membrane perforations 
and the implant survival. In our study, however, the size of 
the perforation correlates with the implant failure. Although 
the high success rate of implant survival in our study complies 
with the studies, the present study smaller defects up to 5 
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mm have been covered with collagen membrane, and larger 
defects, more than 5 mm, have been additionally sutured to 
close the dehiscence, albeit with higher implant failures. In 
order to avoid the perforation, the surgeon should incorporate 
various precautions into the treatment plan and, thus, reduce 
the risk. The presence of the antral septa increases the risk of 
perforation during the procedure. It has been proposed that 
the regenerative result of the bone-grafting procedure is in-
ferior to sinus membrane perforations and that simultaneous 
implant placement should be conducted following the repair 
of severe perforations [25]. According to the results of the 
present study, the membrane perforation should not be con-
sidered as an absolute contraindication to the simultaneous 
implant placement. However, lower implant survival values 
may appear in the cases of severe perforations.
The present study has showed no significant correlation 
between the occurrence of complications and the type of fill-
ing material used in the maxillary sinus lifting. The new bone 
formation has taken place within 6 months after the sinus lift-
ing procedure. The radiographic evaluation of the lifted areas 
has showed no discrepancies in the amount of the regenerated 
bone between the sinus where only xenografts have been 
used and those where a 1:1 mixture of autogenous bone and 
xenograft particles has been used. The sinus graft infection 
is a major but infrequent complication; a meta-analysis has 
revealed that infections occur in up to 4.7 % of sinus graft pro-
cedures [42]. The treatment modalities of sinus graft infections 
reported in the literature include drainage through the bony 
window and the systematic administration of antibiotics, an 
endoscopic exploration of the sinus and surgical exploration 
and rinsing [39]. The signs and symptoms of the sinus graft 
infections are described in the clinical cases of this paper. 
Doud Galli et al. [56] have stated that the obstruction of the 
sinus by mucosal edentulous and particulate graft material 
may result in sinusitis. They presented the cases of chronic 
sinusitis following a sinus lifting surgery. Timmenga et al. [57] 
have evaluated the influence of sinus lifting on the develop-
ment of maxillary sinus pathology by means of endoscopy. 
Only 4.5 % of the patients have developed sinusitis. It has 
been concluded that the occurrence of postoperative chronic 
sinusitis appears to be limited to the patients with a predisposi-
tion for this condition and these factors need to be considered 
before performing the sinus lifting. Carmelli et al. [40] have 
stated that the appearance of an irregular (more than 5 mm) 
circumferential or complete mucosal thickening is associated 
with an increased risk of the sinus outflow obstruction and 
therefore an ENT consultation is recommended. Five patients 
have undergone an endoscopic inspection via the nasal cavity, 
which has indicated a maxillary sinus osteum obstruction 
that has been cleared with endoscopy, the drainage has been 
provided and a full recovery has been obtained. Urban and 
colleagues [43] have described a treatment regime for infected 
grafted sinuses with no defective communications between 
the infected graft and the sinus cavity. They have presented 
the successful usage of surgical and pharmacological regimes 
to treat this complication that does not necessitate a complete 
removal of the graft. The patients with a communication 
between the infected graft and the sinus cavity or those who 
have developed the infection have been treated aggressively 
by a complete graft removal and/or endoscope sinus surgery. 
Our cohort patients have experienced the moderate sinus graft 
infections which have been controlled by a local approach 
supported by the antibiotic administration. Early evaluation 
of the symptoms is critical to prevent a spread of the infec-
tion and its progression to the sinus cavity and additional 
vital structures which, in turn, may lead to a complete graft 
removal. A report of a new bone formation without a graft 
material during the sinus elevation demonstrates a similar 
phenomenon [58], as well as in cases of the spontaneous 
bone regeneration after a postoperative sinus graft infection 
[44]. This study also presents a phenomenon, where a dense 
solid bone has been in the superior spot of the grafted area, 
in spite of an inflammatory complication that necessitates 
a surgical treatment. This dome has provided a 3 to 4 wall 
defect inside the grafted sinus, which has been repaired with 
regenerated bone and permitted the implant insertion with-
out the need of additional sinus lifting. It is noteworthy that 
there are alternative treatments for the cases of the acute sinus 
infection. These include the removal of the infected grafted 
materials as well as regrafting or placing a membrane over 
the window to prevent soft tissue ingrowths. The incidence of 
peri-implantitis of different degrees, which has been identified 
in 18% of the placed implants in our study correlates with the 
results of the recently reported studies. The Lindhe & Meyle 
[59] consensus report shows that peri-implant infections of 
all types of implant therapy are a very common lesion. They 
report that peri-implant mucositis has occurred in 80% of the 
subjects and in 50% of the implant sites. Peri-implantitis has 
been identified in 28-56% of the subjects and in 12-43% of 
the implant sites. Peri-implant infections are usually linked 
with a poor oral hygiene, a history of periodontitis [60] and 
cigarette smoking. Other risk factors such as diabetes, alcohol 
consumption and genetics are defined to a less extent. Dental 
implants migrated to paranasal sinuses have been reported 
over the last 15 years, a total of 62 implants migrated to 
paranasal sinuses have been described in the last few years. 
There are two phases of migration characteristic of implants 
located in the sinus cavity: (a) the displacement of dental 
implants during their placement, (b) the migration of dental 
implants after their Osseo integration. The displacement of 
dental implants during their placement is easily understand-
able. It can be related to the poor bone quality or quantity, 
the surgical inexperience of the operator, the presence of an 
untreated perforation, an excessive tapping on the implant or 
the application of an excessive force [38]. The migration of the 
implant from its initial position to the maxillary sinus may 
occur two weeks or two months later, or after several years of 
its adequate functioning. The implant migration may cause 
the sinus disorder as in the cases described by Regev and as-
sociates [30], or the patient may remain asymptomatic like in 
the present cases. The reasons for the implant migration are 
still unknown. It can be an inadequate implant anchorage and, 
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therefore, a lack of primary stability as well as an inadequate 
preparation or placement of the implant or weakness of the 
bone as a result of osteoporosis or osteopenia. However, the 
mechanism of an implant migration to the maxillary sinus 
several years after its loading is easier to understand and 
this has been the case of the patient presented in our study 
whose implant migrated after 8 years of functioning. Various 
mechanisms have been proposed to explain the migration of 
an implant to the maxillary sinus, and these fall under 3 main 
headings: 1) changes in intrasinusal and nasal pressures; 2) an 
autoimmune reaction to the implant, causing the peri-implant 
bone destruction and endangering an Osseo integration; 3) 
the resorption produced by an incorrect distribution of oc-
clusal force as proposed by Regev and coworkers [30]. Moreno 
et.al [61] has showed that the incidence of implant migration 
to the sinus cavity is higher for the cylindrical implants as 
compared to conical ones as well as for the narrower implants 
and when the implants were placed in smokers. In one case 
of our study a cylindrical implant migrated to the sinus cav-
ity several years after its loading. The implant displacement 
or migration to the maxillary sinus is an increasingly serious 
complication influenced by multiple implants, patients and 
surgeons related factors. Understanding that helps to identify 
these factors minimizes the risk of developing this undesir-
able complication.
Conclusion
A sinus floor elevation is a predictable procedure with 
low morbidity and an expected implant survival rate well 
above 90% for midterm and long-term periods. Complica-
tions may occur during and after the sinus surgery. The 
implant placement in atrophic sites commonly requires the 
site development and, therefore, advanced surgical skill and 
experience to reduce the risk of complications. The presence 
of complications, which can occur despite the taken precau-
tions, emphasizes the importance of thorough clinical and 
radiograph evaluation before performing the sinus lifting 
procedure. It is also recommended to expand the routine 
dental CT scans to include the maxillary sinus ostium to 
ensure that the nasoostium is patent. Early recognition of 
the signs and symptoms of the sinus graft infection is crucial 
to eliminate the infection and prevent its progression to the 
sinus cavity and additional vital structures. The intraoperative 
sinus membrane perforation does not represent a significant 
risk factor for the implant survival.
The sinus infection has occurred in 4.5% of patients which 
complies with the modern literature.
We need to educate our dentists concerning the risks 
associated with the atrophic maxillary posterior area and 
recommend an advanced training and cooperation as well as 
encourage the referrals and teamwork. These should be the 
ways to prevent the complications.
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